- Home
- DBI vs SGHT Comparison
DBI vs SGHT Comparison
Compare DBI & SGHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBI
- SGHT
- Stock Information
- Founded
- DBI 1991
- SGHT 2011
- Country
- DBI United States
- SGHT United States
- Employees
- DBI N/A
- SGHT N/A
- Industry
- DBI Clothing/Shoe/Accessory Stores
- SGHT Medical Specialities
- Sector
- DBI Consumer Discretionary
- SGHT Health Care
- Exchange
- DBI Nasdaq
- SGHT Nasdaq
- Market Cap
- DBI 292.2M
- SGHT 304.4M
- IPO Year
- DBI 1991
- SGHT 2021
- Fundamental
- Price
- DBI $5.54
- SGHT $4.02
- Analyst Decision
- DBI Hold
- SGHT Buy
- Analyst Count
- DBI 3
- SGHT 6
- Target Price
- DBI $6.50
- SGHT $6.80
- AVG Volume (30 Days)
- DBI 1.8M
- SGHT 283.3K
- Earning Date
- DBI 12-10-2024
- SGHT 11-07-2024
- Dividend Yield
- DBI 3.70%
- SGHT N/A
- EPS Growth
- DBI N/A
- SGHT N/A
- EPS
- DBI N/A
- SGHT N/A
- Revenue
- DBI $3,059,173,000.00
- SGHT $79,543,000.00
- Revenue This Year
- DBI $0.78
- SGHT $2.18
- Revenue Next Year
- DBI $3.19
- SGHT $8.14
- P/E Ratio
- DBI N/A
- SGHT N/A
- Revenue Growth
- DBI N/A
- SGHT N/A
- 52 Week Low
- DBI $4.36
- SGHT $2.58
- 52 Week High
- DBI $12.84
- SGHT $8.45
- Technical
- Relative Strength Index (RSI)
- DBI 54.87
- SGHT 39.37
- Support Level
- DBI $4.76
- SGHT $3.86
- Resistance Level
- DBI $5.69
- SGHT $4.11
- Average True Range (ATR)
- DBI 0.34
- SGHT 0.22
- MACD
- DBI 0.08
- SGHT 0.07
- Stochastic Oscillator
- DBI 86.49
- SGHT 40.66
About DBI Designer Brands Inc.
Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment, and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.